|
|
|
Insider
Information: |
Davis Todd C |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
246,065 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$9,868,231 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
246,065 |
|
|
Total
Value |
$9,868,231 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
3
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
39.4%
|
24.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Chief Executive Office... |
2024-03-25 |
120,160 |
2007-05-31 |
0 |
Premium* |
|
Biodelivery Sciences Internation... |
BDSI |
Director |
2022-03-22 |
0 |
2018-08-14 |
0 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2022-08-04 |
125,905 |
2020-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VXRT |
Vaxart Inc |
Director |
|
2019-10-25 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
180,000 |
|
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-04-28 |
4 |
S |
$3.28 |
$196,500 |
D/D |
(60,000) |
120,000 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2021-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,470 |
118,530 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2022-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,375 |
125,905 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-31 |
4/A |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2008-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2009-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
15,000 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
25,979 |
40,979 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,372 |
14,201 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-08-10 |
4 |
B |
$10.90 |
$163,500 |
D/D |
15,000 |
29,201 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2012-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,517 |
35,718 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2013-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,318 |
40,036 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-03-18 |
4 |
S |
$79.45 |
$198,637 |
D/D |
(2,500) |
37,536 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-03-19 |
4 |
S |
$79.63 |
$398,147 |
D/D |
(5,000) |
32,536 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,817 |
34,353 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,426 |
35,779 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-08-06 |
4 |
OE |
$8.58 |
$232,288 |
D/D |
19,670 |
55,449 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-12-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
50 |
55,399 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
810 |
56,209 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-10-31 |
4 |
OE |
$32.30 |
$638,362 |
D/D |
13,980 |
70,189 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
48 |
70,141 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
70,807 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
74 |
70,733 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-02-26 |
4 |
S |
$153.58 |
$742,536 |
D/D |
(4,835) |
65,898 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-02-27 |
4 |
S |
$151.90 |
$1,873,709 |
D/D |
(12,335) |
53,563 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|